What is TATT's health score?

TAT TECHNOLOGIES LTD (TATT) has a TradeApes health score of 50 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is TATT's estimated fair value?

Based on our 5-year discounted cash flow model, TAT TECHNOLOGIES LTD's estimated fair value is $13.45 per share, representing a -68.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is TATT undervalued or overvalued?

Our model currently rates TATT as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for TATT... Refresh in a moment for the full analysis.

TAT TECHNOLOGIES LTD (TATT)

Consumer Cyclical Overvalued low mixed

$42.82

Updated: 2026-06-04

TradeApes Score

Financial Strength

80 Strong

Operating Trend

68 Healthy

Relative Value

0 Stressed

Capital Allocation

45 Mixed

Risk

65 Healthy

Est. Fair Value $13.45

DCF Upside -68.6%

Sector Rank #1241 of 3089

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.